Mark O’Sullivan
speaker
35 appearances
1 recordings
1 series
first heard Oct 2025
last heard 20 Oct
Mark O’Sullivan’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Oct 2025 with 1.
Appearances
So I suppose Enterprise Ireland, for one, has support across the board.
And in particular, maybe when you're kind of in the space of spinning out from research centres, but also, I suppose, even on a more local level, there's accelerators like Ignite, which you mentioned, across the board that help.
And I suppose, in general, as a start-up,
You're kind of taking whatever early stage wins you have to get the first bit of funding in and you try and turn that bit of funding into some inflection point to get the next tranche of funding.
And I think we have a great ecosystem for that in terms of helping you get the early wins.
Yeah, I mean, we're in the process now of raising another funding round as well for next year.
So it definitely helps with that and gets a bit more kind of profile on the market as well.
And in general, I suppose we can have the best technology in the world, but we still need to show that there's kind of commercial traction there.
So in general, I think...
The Irish market, as I said, it has been huge, even in terms of the number of strategic players in the market as well.
A lot of companies that we would like to work with in the future.
So great from that perspective.
But in the shorter term, I suppose it's back on us to make sure that we get through all the milestones that we need to get through in terms of market clearances.
So that's the major focus for us in the short term is getting through those milestones.
and then hopefully we're getting more clinical trials as well and that would be kind of the piece that will hopefully get us the evidence to show that the device can actually improve clinical processes and outcomes.
Showing 21–35 of 35 · page 2 of 2
← Previous